Allopurinol Maintenance Study for Bipolar Disorder
Status:
Terminated
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy of allopurinol as an augmentation
agent for the prevention of mania in bipolar disorder patients with currently stable mood.
Phase:
Phase 4
Details
Lead Sponsor:
Cedars-Sinai Medical Center
Collaborators:
West Coast College of Biological Psychiatry West Coast College of Biological Psychiatry Inc